As of yesterday, March 23rd 2017, a new company – AO Kirov Plasma – has been established in Russia to implement the Memorandum of Understanding signed last year by Russian companies National Immunobiological Company (Nacimbio) and Pharmstandard, and by Kedrion Biopharma.
Kedrion has named Andrea Benassi as its representative on the Board of Directors.
